Osteopontin Upregulation in Atherogenesis Is Associated with Cellular Oxidative Stress Triggered by the Activation of Scavenger Receptors

Archives of Medical Research

Volumn 43, Issue 2, 2012, Pages 102-111

  Jiménez Corona, Azucena E ^a   Damián Zamacona, Salvador ^b   Pérez Torres, Armando ^c   Moreno, Abel ^a   Mas Oliva, Jaime ^b  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b INSTITUTO DE FISIOLOGÍA CELULAR   (Mexico)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Atherosclerosis; Osteopontin; Oxidative stress; Oxidized low density lipoproteins; Scavenger receptor; Vascular calcification

Indexed keywords

CALCIUM PHOSPHATE; COLLAGEN; ELASTIN; LOW DENSITY LIPOPROTEIN; OSTEOPONTIN; REACTIVE OXYGEN METABOLITE; SCAVENGER RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL CALCIFICATION; CHOLESTEROL DIET; CONTROLLED STUDY; ENDOTHELIUM CELL; EXPERIMENTAL RABBIT; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HYPERCHOLESTEROLEMIA; IMMUNOHISTOCHEMISTRY; MALE; NEOINTIMA; NONHUMAN; OXIDATIVE STRESS; SMOOTH MUSCLE FIBER; TISSUE HOMOGENATE; TRANSMISSION ELECTRON MICROSCOPY; UPREGULATION; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

ANIMALS; ATHEROSCLEROSIS; BLOTTING, WESTERN; CELL LINE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; OSTEOPONTIN; OXIDATIVE STRESS; RABBITS; RECEPTORS, SCAVENGER; UP-REGULATION;

EID: 84860606111     PISSN: 01884409     EISSN: 18735487     Source Type: Journal    
DOI: 10.1016/j.arcmed.2012.03.001     Document Type: Article

References (61)

1. London G.M., Guerin A.P., Marchais S.J., et al. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 2003, 18:1731-1740.
2. Wayhs R., Zelinger A., Raggi P. High coronary artery calcium scores pose an extremely elevated risk for hard events. J Am Coll Cardiol 2002, 39:225-230.
3. Adams J.C., Watt F.M. Regulation of development and differentiation by the extracellular matrix. Development 1993, 117:1183-1198.
4. Daniels K., Solursh M. Modulation of chondrogenesis by the cytoskeleton and extracellular matrix. J Cell Sci 1991, 100:249-254.
5. Canfield A.E., Farrington C., Dziobon M.D., et al. The involvement of matrix glycoproteins in vascular calcification and fibrosis: an immunohistochemical study. J Pathol 2002, 196:228-234.
6. Rekhter M.D. Collagen synthesis in atherosclerosis: too much and not enough. Cardiovasc Res 1999, 41:376-384.
7. Watson K.E., Parhami F., Shin V., et al. Fibronectin and collagen I matrixes promote calcification of vascular cells in vitro, whereas collagen IV matrix is inhibitory. Arterioscler Thromb Vasc Biol 1998, 18:1964-1971.
8. Mohler E.R., Gannon F., Reynolds C., et al. Bone formation and inflammation in cardiac valves. Circulation 2001, 103:1522-1528.
9. Fitzpatrick L.A., Turner R.T., Ritman E.R. Endochondral bone formation in the heart: a possible mechanism of coronary calcification. Endocrinology 2003, 144:2214-2219.
10. Giachelli C.M., Bae N., Almeida M., et al. Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. J Clin Invest 1993, 92:1686-1696.
11. Speer M.Y., Chien Y.C., Quan M., et al. Smooth muscle cells deficient in osteopontin have enhanced susceptibility to calcification in vitro. Cardiovasc Res 2005, 66:324-333.
12. Rajamannan N.M., Nealis T.B., Subramaniam M., et al. Calcified rheumatic valve neoangiogenesis is associated with vascular endothelial growth factor expression and osteoblast-like bone formation. Circulation 2005, 111:3296-3301.
13. Jimenez-Corona A.E., Perez-Torres A., Mas-Oliva J., et al. Effect of osteopontin, chondroitin sulfates (B, C), and human serum albumin on the crystallization behavior of hydroxyapatite in agarose and silica hydrogels. Crystal Growth Design 2008, 8:1335-1339.
14. Liaw L., Almeida M., Hart C.E., et al. Osteopontin promotes vascular cell adhesion and spreading and is chemotactic for smooth muscle cells in vitro. Circ Res 1994, 74:214-224.
15. Towler D.A., Bidder M., Latifi T., et al. Diet-induced diabetes activates an osteogenic gene regulatory program in the aortas of low density lipoprotein receptor-deficient mice. J Biol Chem 1998, 273:30427-30434.
16. Aguilar-Gaytan R., Mas-Oliva J. Oxidative stress impairs endocytosis of the scavenger receptor class A. Biochem Biophys Res Commun 2003, 305:510-517.
17. Manzano-Leon N., Delgado-Coello B., Mas-Oliva J., et al. Beta-adaptin: key molecule for microglial scavenger receptor function under oxidative stress. Biochem Biophys Res Commun 2006, 351:588-594.
18. Guaderrama-Diaz M., Solis C.F., Velasco-Loyden G., et al. Control of scavenger receptor-mediated endocytosis by novel ligands of different length. Mol Cell Biochem 2005, 271:123-132.
19. de Winther M.P., van Dijk K.W., Havekes L.M., et al. Macrophage scavenger receptor class A: a multifunctional receptor in atherosclerosis. Arterioscler Thromb Vasc Biol 2000, 20:290-297.
20. Paresce D.M., Ghosh R.N., Maxfield F.R. Microglial cells internalize aggregates of the Alzheimer's disease amyloid beta-protein via a scavenger receptor. Neuron 1996, 17:553-565.
21. Mietus-Snyder M., Gowri M.S., Pitas R.E. Class A scavenger receptor up-regulation in smooth muscle cells by oxidized low density lipoprotein. Enhancement by calcium flux and concurrent cyclooxygenase-2 up-regulation. J Biol Chem 2000, 275:17661-17670.
22. Mietus-Snyder M., Glass C.K., Pitas R.E. Transcriptional activation of scavenger receptor expression in human smooth muscle cells requires AP-1/c-Jun and C/EBPbeta: both AP-1 binding and JNK activation are induced by phorbol esters and oxidative stress. Arterioscler Thromb Vasc Biol 1998, 18:1440-1449.
23. Calvo D., Gomez-Coronado D., Suarez Y., et al. Human CD36 is a high affinity receptor for the native lipoproteins HDL, LDL, and VLDL. J Lipid Res 1998, 39:777-788.
24. Rigotti A., Acton S.L., Krieger M. The class B scavenger receptors SR-BI and CD36 are receptors for anionic phospholipids. J Biol Chem 1995, 270:16221-16224.
25. Chen M., Masaki T., Sawamura T. LOX-1, the receptor for oxidized low-density lipoprotein identified from endothelial cells: implications in endothelial dysfunction and atherosclerosis. Pharmacol Ther 2002, 95:89-100.
26. Aoyama T., Fujiwara H., Masaki T., et al. Induction of lectin-like oxidized LDL receptor by oxidized LDL and lysophosphatidylcholine in cultured endothelial cells. J Mol Cell Cardiol 1999, 31:2101-2114.
27. Kritchevsky D., Tepper S.A., Langan J. Cholesterol vehicle in experimental atherosclerosis. IV. Influence of heated fat and fatty acids. J Atheroscler Res 1962, 2:15-22.
28. Allen T.C. Hematoxylin and eosin. Laboratory Methods in Histotechnology 1992, 53. Armed Forces Institute of Pathology, Washington, DC. E.B. Prophet, B. Millis, J.B. Arrington, L.H. Sobin (Eds.).
29. Johnson F.B. Pigments and minerals. Laboratory Methods in Histotechnology 1992, 197-198. Armed Forces Institute of Pathology, Washington, DC. E.B. Prophet, B. Millis, J.B. Arrington, L.H. Sobin (Eds.).
30. Shi S.R., Chaiwun B., Young L., et al. Antigen retrieval technique utilizing citrate buffer or urea solution for immunohistochemical demonstration of androgen receptor in formalin-fixed paraffin sections. J Histochem Cytochem 1993, 41:1599-1604.
31. Sawamura T., Kume N., Aoyama T., et al. An endothelial receptor for oxidized low-density lipoprotein. Nature 1997, 386:73-77.
32. Dejager S., Mietus-Snyder M., Friera A., et al. Dominant negative mutations of the scavenger receptor. Native receptor inactivation by expression of truncated variants. J Clin Invest 1993, 92:894-902.
33. Pitas R.E., Innerarity T.L., Weinstein J.N., et al. Acetoacetylated lipoproteins used to distinguish fibroblasts from macrophages in vitro by fluorescence microscopy. Arteriosclerosis 1981, 1:177-185.
34. Innerarity T.L., Pitas R.E., Mahley R.W. Lipoprotein-receptor interactions. Methods Enzymol 1986, 129:542-565.
35. Senger D.R., Asch B.B., Smith B.D., et al. A secreted phosphoprotein marker for neoplastic transformation of both epithelial and fibroblastic cells. Nature 1983, 302:714-715.
36. Rittling S.R., Feng F. Detection of mouse osteopontin by western blotting. Biochem Biophys Res Commun 1998, 250:287-292.
37. Kasugai S., Zhang Q., Overall C.M., et al. Differential regulation of the 55 and 44 kDa forms of secreted phosphoprotein 1 (OPN, osteopontin) in normal and transformed rat bone cells by osteotropic hormones, growth factors and a tumor promoter. Bone Mineral 1991, 13:235-250.
38. Saitoh Y., Kuratsu J., Takeshima H., et al. Expression of osteopontin in human glioma. Its correlation with the malignancy. Lab Invest 1995, 72:55-63.
39. Miyazaki Y., Setoguchi M., Yoshida S., et al. The mouse osteopontin gene. Expression in monocytic lineages and complete nucleotide sequence. J Biol Chem 1990, 265:14432-14438.
40. Castellano G., Malaponte G., Mazzarino M.C., et al. Activation of the osteopontin/matrix metalloproteinase-9 pathway correlates with prostate cancer progression. Clin Cancer Res 2008, 14:7470-7480.
41. Isoda K., Nishikawa K., Kamezawa Y., et al. Osteopontin plays an important role in the development of medial thickening and neointimal formation. Circ Res 2002, 91:77-82.
42. Olsson M., Thyberg J., Nilsson J. Presence of oxidized low density lipoprotein in nonrheumatic stenotic aortic valves. Arterioscler Thromb Vasc Biol 1999, 19:1218-1222.
43. Mohler E.R., Chawla M.K., Chang A.W., et al. Identification and characterization of calcifying valve cells from human and canine aortic valves. J Heart Valve Dis 1999, 8:254-260.
44. Kaden J.J., Bickelhaupt S., Grobholz R., et al. Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulate aortic valve calcification. J Mol Cell Cardiol 2004, 36:57-66.
45. Hsu H.H., Camacho N.C., Tawfik O., et al. Induction of calcification in rabbit aortas by high cholesterol diets: roles of calcifiable vesicles in dystrophic calcification. Atherosclerosis 2002, 161:85-94.
46. Tyson K.L., Reynolds J.L., McNair R., et al. Osteo/chondrocytic transcription factors and their target genes exhibit distinct patterns of expression in human arterial calcification. Arterioscler Thromb Vasc Biol 2003, 23:489-494.
47. Parhami F., Basseri B., Hwang J., et al. High-density lipoprotein regulates calcification of vascular cells. Circ Res 2002, 91:570-576.
48. Proudfoot D., Davies J.D., Skepper J.N., et al. Acetylated low-density lipoprotein stimulates human vascular smooth muscle cell calcification by promoting osteoblastic differentiation and inhibiting phagocytosis. Circulation 2002, 106:3044-3050.
49. Li X., Yang H.Y., Giachelli C.M. BMP-2 promotes phosphate uptake, phenotypic modulation, and calcification of human vascular smooth muscle cells. Atherosclerosis 2008, 199:271-277.
50. Cheng S.L., Shao J.S., Charlton-Kachigian N., et al. MSX2 promotes osteogenesis and suppresses adipogenic differentiation of multipotent mesenchymal progenitors. J Biol Chem 2003, 278:45969-45977.
51. Kossmehl P., Schonberger J., Shakibaei M., et al. Increase of fibronectin and osteopontin in porcine hearts following ischemia and reperfusion. J Mol Med 2005, 83:626-637.
52. Okamoto H. Osteopontin and cardiovascular system. Mol Cell Biochem 2007, 300:1-7.
53. Giachelli C.M., Lombardi D., Johnson R.J., et al. Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivo. Am J Pathol 1998, 152:353-358.
54. Ashkar S., Weber G.F., Panoutsakopoulou V., et al. Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science 2000, 287:860-864.
55. 2+-flux pathways in canine venous endothelial cells. Biochem J 1994, 297:209-215.
56. Finkel T. Oxygen radicals and signaling. Curr Opin Cell Biol 1998, 10:248-253.
57. 2+ release from vascular smooth muscle sarcoplasmic reticulum. Am J Physiol 1992, 262:H114-H116.
58. Wang K.X., Denhardt D.T. Osteopontin: role in immune regulation and stress responses. Cytokine Growth Factor Rev 2008, 19:333-345.
59. Hsu H.Y., Chiu S.L., Wen M.H., et al. Ligands of macrophage scavenger receptor induce cytokine expression via differential modulation of protein kinase signaling pathways. J Biol Chem 2001, 276:28719-28730.
60. Mietus-Snyder M., Friera A., Glass C.K., et al. Regulation of scavenger receptor expression in smooth muscle cells by protein kinase C: a role for oxidative stress. Arterioscler Thromb Vasc Biol 1997, 17:969-978.
61. Partridge C.R., He Q., Brun M., et al. Genetic networks of cooperative redox regulation of osteopontin. Matrix Biol 2008, 27:462-474.